Select Medical (SEM) Rating Increased to Buy at Zacks Investment Research
Zacks Investment Research upgraded shares of Select Medical (NYSE:SEM) from a hold rating to a buy rating in a research report sent to investors on Tuesday. Zacks Investment Research currently has $21.00 target price on the health services provider’s stock.
According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “
SEM has been the topic of several other reports. ValuEngine raised Select Medical from a buy rating to a strong-buy rating in a research report on Thursday, March 1st. Robert W. Baird reaffirmed a buy rating and issued a $26.00 target price on shares of Select Medical in a research report on Friday, February 23rd. TheStreet raised Select Medical from a c+ rating to a b- rating in a report on Thursday, March 1st. JMP Securities raised Select Medical from an underperform rating to a market perform rating and set a $12.00 price target on the stock in a report on Tuesday, February 27th. Finally, Bank of America raised Select Medical from an underperform rating to a neutral rating and set a $19.00 price target on the stock in a report on Thursday, January 4th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company presently has an average rating of Buy and a consensus target price of $20.63.
Select Medical (NYSE:SEM) last issued its earnings results on Wednesday, February 21st. The health services provider reported $0.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.19 by $0.12. Select Medical had a return on equity of 14.27% and a net margin of 3.99%. The firm had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same period last year, the company earned $0.12 earnings per share. The firm’s revenue for the quarter was up 6.5% on a year-over-year basis. equities analysts anticipate that Select Medical will post 1.07 EPS for the current fiscal year.
In other news, insider Scott A. Romberger sold 5,000 shares of the firm’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of $18.46, for a total transaction of $92,300.00. Following the transaction, the insider now directly owns 167,811 shares of the company’s stock, valued at $3,097,791.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Martin F. Jackson sold 134,029 shares of the firm’s stock in a transaction on Friday, December 22nd. The shares were sold at an average price of $17.05, for a total value of $2,285,194.45. Following the transaction, the insider now directly owns 1,717,944 shares in the company, valued at $29,290,945.20. The disclosure for this sale can be found here. Insiders have sold 139,352 shares of company stock worth $2,383,002 over the last three months. Corporate insiders own 19.86% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. grew its holdings in Select Medical by 3.0% during the fourth quarter. BlackRock Inc. now owns 13,836,694 shares of the health services provider’s stock worth $244,216,000 after acquiring an additional 408,230 shares during the period. Dimensional Fund Advisors LP grew its holdings in Select Medical by 1.8% during the third quarter. Dimensional Fund Advisors LP now owns 8,289,370 shares of the health services provider’s stock worth $159,154,000 after acquiring an additional 146,892 shares during the period. Orbimed Advisors LLC grew its holdings in Select Medical by 51.3% during the third quarter. Orbimed Advisors LLC now owns 5,578,500 shares of the health services provider’s stock worth $107,107,000 after acquiring an additional 1,891,100 shares during the period. Hood River Capital Management LLC grew its holdings in Select Medical by 133.0% during the fourth quarter. Hood River Capital Management LLC now owns 2,407,432 shares of the health services provider’s stock worth $42,491,000 after acquiring an additional 1,374,111 shares during the period. Finally, Victory Capital Management Inc. grew its holdings in Select Medical by 2.3% during the fourth quarter. Victory Capital Management Inc. now owns 1,252,350 shares of the health services provider’s stock worth $22,104,000 after acquiring an additional 27,997 shares during the period. 79.80% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This news story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/03/14/select-medical-sem-rating-increased-to-buy-at-zacks-investment-research.html.
Select Medical Company Profile
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.